| Prasugrel Maleic acid |
|
| (CAS 389574-20-3) |
 |
| Description： |
Prasugrel Maleic acid is a platelet inhibitor with IC50 value of 1.8 μM.
Target: P2Y12 receptor
Prasugrel Maleic acid is a novel platelet inhibitor used for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.
Prasugrel Maleic acid reduces the aggregation ("clumping") of platelets by irreversibly binding to P2Y12 receptors. In rat platelets, prasugrel Maleic acid AM inhibited in vitro platelet aggregation induced by ADP (10 μm) with an IC50 value of 1.8 Μm.
Clinical indications: Acute coronary syndrome; Ischemic heart disease; Sickle cell anemia; Stroke; Vascular occlusive disease
FDA Approved Date: February 2009
Toxicity: Hypertension; Headache; Hypercholesterolemia/hyperlipidemia; Nausea; Epistaxis
|
| Product No. |
KT20150 |
| Product Name |
Prasugrel Maleic acid |
| Synonyms |
Effient Maleic acid |
| Formal Name |
|
| CAS Number |
389574-20-3 |
| Molecular Formula |
C24H24FNO7S |
| Formula Weight |
489.51 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AZD1283
Clopidogrel
MARS 2578
Prasugrel hydrochloride
Prasugrel maleic acid
Ticagrelor
Sitagliptin phosphate monohydrate
Tirofiban hydrochloride monohydrate
Aliskiren
Aliskiren hemifumarate
Nebivolol Hydrochloride
Orlistat
L(-)-Carnitine
L-Carnitine Tartrate
L-Carnitine HCL
|
|
